• The template for this display is not available. Please contact a Site administrator.

Hyperparathyroidism, hypophosphatemia & hypercalcemia


Assessing the Clinical and Laboratory Parameters


This scenario is unusual because of the hypophosphatemia – otherwise the pattern is consistent with failing medical management of secondary hyperparathyroidism


Less than 1% of all patients are in this category.



Dialysis Prescription

Dialysis Prescription

Reduction in the dialysate calcium by 0.25-0.50 mmol/L (0.50 – 1.0 mEq/L) may alleviate the hypercalcemia, but will also exacerbate the secondary hyperparathyroidism



Return to bone and mineral resource home